Absorption |
Blood-Brain Barrier | BBB- | 0.7101 |
Human Intestinal Absorption | HIA+ | 0.9356 |
Caco-2 Permeability | Caco2- | 0.8520 |
P-glycoprotein Substrate | Non-substrate | 0.8405 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9777 |
Non-inhibitor | 0.9905 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9337 |
Distribution |
Subcellular localization | Mitochondria | 0.6152 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8174 |
CYP450 2D6 Substrate | Non-substrate | 0.8358 |
CYP450 3A4 Substrate | Non-substrate | 0.7782 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8645 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8281 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9627 |
CYP450 2C19 Inhibitor | Inhibitor | 0.5778 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7324 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9157 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9689 |
Non-inhibitor | 0.9676 |
AMES Toxicity | Non AMES toxic | 0.9388 |
Carcinogens | Non-carcinogens | 0.8045 |
Fish Toxicity | High FHMT | 0.7863 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.6453 |
Honey Bee Toxicity | Low HBT | 0.6131 |
Biodegradation | Ready biodegradable | 0.6246 |
Acute Oral Toxicity | III | 0.8063 |
Carcinogenicity (Three-class) | Non-required | 0.7288 |